Faculty Bibliography

Exercise-induced bronchospasm (EIB) is often inferred from the reduction after exercise in one arbitrarily selected value derived from the maximum expiratory flow-volume (MEFV) curve (eg, FEV1) on a single test; however, patients with symptoms of EIB not meeting these criteria may risk being undiagnosed. To assess the ability of repeated tests using additional MEFV parameters in identifying EIB-prone patients, we investigated the effects of exercise provocation on the MEFV curve on two separate occasions. Of 95 patients with symptoms of EIB, 61 had reproducible exercise-induced changes (< 10 percent intraresponse variation), falling into four patterns: 27 (44 percent) had significantly reduced VC and airflow throughout the MEFV curve; 18 (30 percent) had unchanged VC but decreased airflow throughout the curve; 11 (18 percent) had reduced airflow above 50 percent VC but not below 50 percent VC; and 5 (8 percent) had significant reductions in airflow only at 50 percent VC or below. Of the other 34 subjects, 18 had no apparent response, and 16 responded on only one occasion, making objective assessment of these patients' EIB equivocal. We conclude that for a given individual, failure to meet arbitrary criteria does not rule out EIB. Additionally, a more subjective approach that integrates, among other factors, all routine MEFV curve parameters taken from multiple tests with clinical symptoms and history provide a more accurate assessment of EIB

Strength training of neck muscles, a potentially important approach to injury prevention and rehabilitation, has been limited by the lack of a convenient means of instituting progressive resistance exercise (PRE) programs. By positioning a compressible ball coupled with an air pressure gauge between the head and a wall, eight men, ranging in age from 21 to 46 years, initially measured the maximum voluntary pressure (MVP) generated within the ball (a measure of neck muscle force), while maximally flexing, extending, and laterally flexing their head into the ball. In accordance with PRE principles, they then performed three sets of 10 repetitions of each motion while maintaining ball pressure at 60-80% of the measured MVP. This training program, consisting of three to five sessions per week for 4-7 weeks: 1) increased the MVPs for flexion [to 156 +/- 9% (SE) pretraining, p < 0.05], extension [to 162 +/- 11% (SE) pretraining, p < 0.05], and lateral flexion [to 173 +/- 12% (SE) pretraining, p < 0.05]; and 2) decreased the disparity between the MVPs for left and right lateral flexion, indicating that the weaker side showed greater improvement than the stronger side (p < 0.05). These findings demonstrate that progressive resistance neck exercises, facilitated by a compressible ball coupled with an air pressure gauge, can markedly increase neck muscle strength and decrease lateral force imbalance. J Orthop Sports Phys Ther 1992;16(6):275-280.

Since Maimonides, it has been common in folk medicine to proscribe milk for asthmatics because its putative stimulation of mucus production can exacerbate asthma symptoms. A literature review, however, failed to reveal any data supporting this notion. We, therefore, compared the effects of ingesting 16 oz. of whole milk (16 g lipid), skim milk (2 g lipid), and water (each on a separate day) on: (1) forced expiratory volume in 1 second (FEV1), (2) forced expiratory flow at 50% of vital capacity (V50), and (3) pulmonary diffusing capacity (DLCO) in 11 asthmatic and 10 nonasthmatic subjects. Measurements were taken at 30 minute intervals for 3 hours. The two milk types did not significantly change FEV1 or V50 in either group, indicating that the amount ingested did not change airway resistance sufficiently to alter airflow parameters. In the asthmatic group, however, DLCO decreased progressively over the 3 hours by 6.8 +/- 1.4% (mean +/- SE) per hour after whole milk (maximum reduction = 21 +/- 1.4%) but not after water or skim milk. In the nonasthmatic group, no significant effects were observed on DLCO after any of the liquids. These data suggest that milk lipids can disturb gas exchange in asthmatic patients

The postoperative courses of 39 patients with severe lung disease (31 with obstructive disease and 8 restrictive) who underwent a cardiac operation were retrospectively reviewed. The stay in the intensive care unit of the study group was 7.9 +/- 10.3 days (mean +/- standard deviation) compared with 2.4 +/- 3.9 days for the control group (100 patients with less impaired pulmonary function) (p less than 0.001). The study group also had a greater number of valve replacements than did the control group (p less than 0.01). Patients with obstructive disease had more respiratory complications than did patients with restrictive disease (p less than 0.05). There were 21 cases of atelectasis. Effusions were noted in 11 patients. Ten patients had bronchospasm. Bronchial secretions were a major problem in 6 patients. Pneumonia developed in 4 patients, and pneumothorax occurred in 3 others. The two in-hospital deaths were not directly related to pulmonary complications. Our findings indicate that (1) patients with severe lung impairment generally do well after a cardiac operation but have more postoperative pulmonary complications than patients with less impairment; (2) patients with restrictive pulmonary disease appear to fare better than those with obstructive disease; (3) pulmonary function tests can alert the clinician to the possible risk of postoperative complications, but they cannot, by themselves, be used to exclude patients from operation; and (4) patients with severe pulmonary impairment facing valve replacement are at greater risk of pulmonary complications than patients having other types of cardiac surgical intervention

Pentoxifylline is a xanthine derivative with hemorrheologic and vascular properties that may improve gas exchange in patients with chronic obstructive pulmonary disease (COPD). We tested this hypothesis in 12 patients with COPD (mean FEV1 = 40 percent predicted; mean DCO, 8.6 ml/min/mm Hg) randomly divided into a treatment and control group and six healthy volunteers. Following establishment of baseline DCO and maximum expiratory flow volume (MEFV) curve values, each subject in the treatment and healthy groups took 400 mg of pentoxifylline three times a day for 12 weeks. Weekly DCO and MEFV curves were measured before treadmill exercise in both COPD groups and before and after exercise in the healthy group. The MEFV curve parameters from the final three weeks of therapy did not differ significantly from baseline values. During this time, however, the treatment COPD group's resting DCO rose by 8.2 +/- 2.4 percent over baseline level (p less than 0.01). Treadmill walk time increased from 17.7 +/- 2.9 minutes to 23.2 +/- 2.9 minutes (p less than 0.02). This was accompanied by improved exercise oxygen saturation measured by oximetry (SoxiO2). Premedication SoxiO2 fell from 92.8 +/- 1.2 percent to 88.6 +/- 2.5 percent during exercise, and from 94.4 +/- 1.1 percent to only 91.8 +/- 1.0 percent after 12 weeks of medication (p less than 0.05). No such improvement was noted in the control COPD group. Although the healthy group's resting SoxiO2 and DCO did not change during treatment, their exercise DCO increased significantly from 36.3 +/- 3.1 ml/min/mm Hg to 41.8 +/- 3.5 ml/min/mm Hg (p less than 0.001). These data demonstrate that pentoxifylline improves gas exchange, possibly by increasing cardiac output, and/or by raising mixed venous PO2, and/or by improving blood flow to underperfused alveoli

We present the case of a young woman with a right aortic arch who first became symptomatic when she began a vigorous exercise program. Her symptoms were very suggestive of exercise-induced bronchospasm. Her flow-volume curves, however, showed evidence of variable intrathoracic large airways obstruction. A magnetic resonance imaging scan confirmed the presence of severe tracheal narrowing caused by her right aortic arch